| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $212K | — | +0.0% |
| R&D Expense | $2.9M | — | -49.9% |
| SG&A Expense | $6.1M | — | +46.1% |
| Operating Income | -$8.7M | — | +9.7% |
| Pre-tax Income | -$8.3M | — | +6.5% |
| Net Income | -$8.3M | — | +12.3% |
| EPS (Basic) | -$1.46 | — | -595.2% |
| EPS (Diluted) | -$1.46 | — | -595.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $41.3M | +31.6% | +179.4% |
| Short-term Investments | $5.5M | -76.5% | -86.2% |
| Current Assets | $53.5M | -12.7% | -6.8% |
| Total Assets | $54.5M | -12.5% | -6.1% |
| Current Liabilities | $4.1M | -2.0% | +5.9% |
| Total Liabilities | $4.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.0M | — | +21.8% |
| Investing Cash Flow | $17.9M | — | +61.5% |
| Financing Cash Flow | $3K | — | — |
| +7.3% |
| Stockholders' Equity | $50.3M | -13.2% | -7.0% |